home / subscribe / donate / books / archives / search / links / feedback / events / faq
Inside the New Print Edition of Our Subscriber-Only Newsletter!
The New Campus McCarthyism
There’s a McCarthyite campaign in full spate across higher education in the U.S. today. For every headline case, like Norman Finkelstein or Joseph Massad, there are three or four less-publicized smear campaigns. In the sights of the witch-hunters are faculty targeted as “anti-Israel”, as terror-symps, as leftists. In our latest newsletter we feature the personal history of Victoria Fontan, a Frenchwoman who came to a US campus from field work in the back alleys of Fallujah and found out just how devastating academic warfare can be. ALSO -- Saving the Florida Everglades – Alan Farago reports from the battlefront. PLUS -- They aimed at Moscow, They Hit Kabul: Serge Halimi on Sarkozy and NATO’s Mission Creep. Get your new edition today by subscribing online or calling 1-800-840-3683 Contributions to CounterPunch are tax-deductible. Click here to make a donation. If you find our site useful please: Subscribe Now! CounterPunch books and gear make great presents.Order CounterPunch By Email For Only $35 a Year !
Meet & Debate (Perhaps Even Date) CPers Online at CounterPunch's New Facebook Page!
|
Today's Stories April 7, 2009 David Price April 6, 2009 Michael Hudson Andy Worthington Bagram: Guantánamo's Dark Mirror Ray McGovern Deepak Tripathi Mike Whitney Norman Solomon Jonathan Cook Judith Bello Deena Metzger Blackwater in Liberia Dr. M. Kamiar Website of the Day April 3-5, 2009 Alexander Cockburn Kathy Kelly / Peter Morici Kathy Sanborn Andy Worthington Rob Larson Saul Landau Steve Early John Goekler Rannie Amiri Dave Lindorff Lee Ballinger Ron Jacobs David Macaray John Wight Keeanga-Yamahtta Taylor Mychal Bell Missy Beattie Reza Fiyouzat Michael Boldin Christopher Brauchli Charles R. Larson Susie Day Stephen Martin Kim Nicolini David Yearsley Phyllis Pollack Poets' Basement Website of the Day
April 2, 2009 Robert Weissman Eric Toussaint / George Bisharat Russell Mokhiber Franklin Lamb Gareth Porter David Macaray Chris Genovali Sam Smith Suzan Mazur Website of the Day
April 1, 2009 Chris Floyd Stanley Heller Mark Brenner, Mischa Gaus and Jane Slaughter Obama's Perilous Plan for Detroit: Restructure the Big 3, But Not With Bankruptcy Jonathan Cook Eric Walberg Richard Morse Don Fitz Laray Polk Belén Fernández Harvey Wasserman Website of the Day March 31, 2009 Uri Avnery Peter Lee Nicholas Dearden Dave Lindorff Joanne Mariner Ron Jacobs Wiliam S. Lind David Michael Green Benjamin Dangl Johnny Barber Dedrick Muhammad Website of the Day March 30, 2009 Michael Hudson Patrick Cockburn Henry A. Giroux Mike Whitney Ralph Nader Paul Craig Roberts Jeremy Scahill Robert Bryce Jonathan Cook Ray McGovern Website of the Day March 27-29, 2009 Alexander Cockburn Arno J. Mayer Michael Hudson José Pertierra Andy Worthington Mike Whitney Winslow T. Wheeler Souad N. Al-Azzawi Dave Lindorff Ian Masters Barbara Rose Johnston Jami Tarn Diane Farsetta David Ker Thomson Against Democracy Ramzy Baroud Rannie Amiri Wajahat Ali Nick Egnatz Gregory A. Burris Missy Beattie Stephen Martin Charles R. Larson David Yearsley Ben Sonnenberg Kim Nicolini Lorenzo Wolff Poets' Basement Website of the Weekend
March 26, 2009 Paul Craig Roberts Sharon Smith Neve Gordon Patrick Madden Gareth Porter Dave Lindorff Hannah Safran Keith Newell Todd Chretien Nelson P. Valdés Website of the Day
March 25, 2009 Robin Blackburn Conn Hallinan David Rosen Jonathan Cook Dean Baker Ron Jacobs Russell Mokhiber David Macaray Dave Lindorff Sarah Knopp Website of the Day
March 24, 2009 Robert Sandels Harvey Wasserman Franklin Lamb Michael Donnelly Norman Solomon Elizabeth Schulte John Goekler Nicole Colson Global Balkans William S. Lind Website of the Day
March 23, 2009 M. Shahid Alam Uri Avnery Mike Whitney Ralph Nader Brian Cloughley Dave Lindorff Amira Hass Chris Irwin Binoy Kampmark Michael Dickinson Website of the Day March 20-22, 2009 Alexander Cockburn Paul Craig Roberts P. Sainath Robert Weissman Saul Landau David Michael Green Greg Moses Ron Jacobs Michael D. Yates John V. Whitbeck Andy Worthington Linn Washington Jr. David Ker Thomson Laurent Jacque Rannie Amiri Reiko Redmonde / David Macaray Kenneth Couesbouc Martha Rosenberg Alan Farago Missy Beattie Richard Rhames Stephen Martin Charles R. Larson David Yearsley Lorenzo Wolff Poets' Basement Website of the Weekend March 19, 2009 Dave Marsh Paul Craig Roberts Mike Whitney Sam Smith Harvey Wasserman Binoy Kampmark Kathy Sanborn Christopher Brauchli George Wuerthner Diann Rust-Tierney Website of the Day
March 18, 2009 Michael Hudson Paul Craig Roberts Nelson P. Valdés Jonathan Cook John Ross Yifat Susskind Dave Lindorff Frances Moore Lappé Richard Grossman Rev. William E. Alberts Website of the Day March 17, 2009 Michael Hudson James G. Abourezk Harry Browne Joanne Mariner Alan Farago Dean Baker Peter Morici Bill and Kathleen Christison Richard Gott Walter Brasch Website of the Day
March 16, 2009 Pam Martens Uri Avnery Mike Whitney Ralph Nader Nikolas Kozloff John Walsh Ron Jacobs Binoy Kampmark Stephen Fleischman Christian Christensen Scott Handleman Website of the Day March 13 / 15, 2009 Alexander Cockburn Peter Lee Diana Johnstone David Harvey Petrino DiLeo David Ker Thomson Eric Ruder Fred Gardner David Yearsley Saul Landau Laura Carlsen Robert Weissman John Goekler / Tom Barry Kathy Sanborn Chris Mobley / Leela Yellesetty David Michael Green Alan Maass / Christopher Brauchli Richard Morse Lorenzo Wolff Poets' Basement Website of the Weekend March 12 , 2009 Sharon Smith Christopher Ketcham Mike Whitney Ray McGovern Eric Toussaint / John Ross M. Reza Pirbhai Chris Floyd Steve Early Quentin Gee Website of the Day March 11 , 2009 Mike Roselle Paul Craig Roberts Henry A. Giroux Nikolas Kozloff Norm Kent Mitu Sengupta Ludwig Watzal David Macaray William S. Lind Martha Rosenberg Website of the Day March 10 , 2009 Franklin Spinney Vijay Prashad Stan Cox Zoltan Grossman Reuven Kaminer Jonathan Cook Dave Lindorff Brian McKenna Harvey Wasserman Corey Pein Website of the Day
March 9 , 2009 Pam Martens Ralph Nader Peter Lee Mike Whitney Peter Morici Dean Baker Steve Ault Stephen Lendman Farooq Sulehria Belén Fernández Website of the Day March 6-8 , 2009 Alexander Cockburn Chris Floyd Uri Avnery Dave Lindorff Mark Weisbrot David Ker Thomson Phil Aliff Rebekah Ward Tracey Briggs Dean Baker Daniel P. Wirt, M.D. Carl Finamore Wajahat Ali David Michael Green David Macaray Michael Dickinson Susie Day Bob Sommer Ben Sonnenberg David Yearsley DC Larson Lorenzo Wolff Poets' Basement Website of the Weekend March 5 , 2009 James G. Abourezk Kathleen and Bill Christison Robert Weissman Patrick Cockburn William Blum Robert Fantina Saul Landau Benjamin Dangl Christopher Brauchli Website of the Day March 4, 2009 Marjorie Cohn Mike Whitney Ron Jacobs Ashley Smith Joanne Mariner Dan Bacher Mark Engler Franklin Lamb Cal Winslow David Mandelzys Website of the Day March 3, 2009 Conn Hallinan Fawzia Afzal-Khan Brian M. Downing Robert Larson Daniel P. Wirt, MD Russell Mokhiber William Loren Katz Kathy Sanborn Pauline Imbach Christopher Ketcham Website of the Day March 2, 2009 Andrea Peacock Paul Craig Roberts Peter Lee John Blair Peter Morici Uri Avnery Michael Donnelly Fred Gardner Sonia Nettnin Andrew Lehman Website of the Day
Tom Barry Harvey Wasserman Adam Turl David Macaray James McEnteer Website of the Day
|
April 7, 2009 Mothers Act Fuels Multi-Billion Dollar IndustryMotherhood and the Psycho-Pharmaceutical ComplexBy EVELYN PRINGLE Motherhood has fallen prey to the psycho-pharmaceutical complex. If new legislation known as the Mother's Act becomes law, the drugging of infants through pregnant and nursing mothers will no doubt increase. The legislation was introduced in the House during the 110th Congress on January 4, 2007, by Illinois Democrat Bobby Rush and later reintroduced into both bodies of the new Congress in January 2009, after the bill died in the Senate last year. Democratic Senator Robert Menendez from New Jersey, home to a large number of drug companies, and Richard Durbin (D-IL) are the main sponsors of the bill in the Senate. In a March 30, 2009 speech on the House floor, Congressman Rush identified the target of this piece of legislation when he claimed that, "60 to 80 percent of new mothers experience symptoms of postpartum depression while the more serious condition, postpartum psychosis, affects up to 20 percent of women who have recently given birth." After the House voted to pass the legislation on that day, the Congressman stated: "H. R. 20 will finally put significant money and attention into research, screening, treatment and education for mothers suffering from this disease." However, he only mentions screening and treatment for postpartum depression. The true goal of the promoters of this Act is to transform women of child bearing age into life-long consumers of psychiatric treatment by screening women for a whole list of "mood" and "anxiety" disorders and not simply postpartum depression. Enough cannot be said about the ability of anyone with a white coat and a medical title to convince vulnerable pregnant women and new mothers that the thoughts and feelings they experience on any given day might be abnormal. The constant watching and barrage of questions such as are you depressed, are you anxious, are you moody, are you fearful of motherhood, are you sleeping well, are there changes in your eating habits, will predictably have the net effect of convincing many women that normal thoughts and emotions are a sign of mental disorders. In the March 13, 2008 NewsWithViews article, "Branding Pregnancy as a Mental Illness," Byron Richards writes: "The Mothers Act has the net affect of reclassifying the natural process of pregnancy and birth as a mental disorder that requires the use of unproven and extremely dangerous psychotropic medications (which can also easily harm the child). The bill was obviously written by the Big Pharma lobby and its passage into law would be considered laughable except that it is actually happening." All of these drugs are now being prescribed to treat the "mood” and "anxiety" disorders that women will be screened for if the Act becomes law. In the case of pregnant women, no psychiatric drug has been FDA approved as safe for use. The newly recruited customers will be stigmatized for life with labels of the most serious forms of mental illness simply because they are unlucky enough to become pregnant in the United States, where serious disorders lead to major profits from the prescribing of multiple classes of psychotropic drugs. On September 1, 2008, Medical News Today ran a headline for a study that stated: "Americans Show Little Tolerance For Mental Illness Despite Growing Belief In Genetic Cause." The study by University of Pennsylvania sociology professor Jason Schnittker showed that while more Americans believe that mental illness has genetic causes, the country is no more tolerant of the mentally ill than it was 10 years ago. The study explored tolerance in terms of: unwillingness to live next door to a mentally ill person, having a group home for the mentally ill in the neighborhood, spending an evening socializing with a mentally ill person, working closely with such a person on the job, making friends with someone with a mental illness or having a mentally ill person marry into the family. Multi-billion dollar industry In an article for AlterNet on June 18, 2008, Dr Bruce Levine, author of the book, "Surviving America's Depression Epidemic," explains how the psycho-pharmaceutical cartel works. "Mental health treatment in the United States is now a multibillion-dollar industry," he reports, "and all the rules of industrial complexes apply." "Not only does Big Pharma have influential psychiatrists... in their pocket, virtually every mental health institution from which doctors, the press, and the general public receive their mental health information is financially interconnected with Big Pharma." "The American Psychiatric Association, psychiatry's professional organization, is hugely dependent on drug company grants, and this is also true for the National Alliance for the Mentally Ill and other so-called consumer organizations." "Harvard and other prestigious university psychiatry departments take millions of dollars from drug companies, and the National Institute of Mental Health funds researchers who are financially connected with drug companies." More Democrats than Republicans are supporting the Mother's Act. The increased campaign funding to Democrats may well explain this turn of events. For the last eight election cycles the pharmaceutical industry has contributed far more to Republicans than Democrats. In the 2006 cycle the percentage was 28% to Democrats and 70% to Republicans, according to the Center for Responsive Politics, a nonprofit group that tracks political funding. But the Democrats were close to matching the Republicans for the 2008 cycle with $5,099,942 to Democrats compared to $5,680,871 to Republicans, which is probably why the Democrats would allow such an obvious drug marketing scheme to be implemented. “The Mothers Act, while appearing like an Act of benevolence, is a dangerous and unnecessary measure that will result in the further over-prescription of drugs that are already grotesquely over-prescribed," says Kate Gillespie, one of the lead attorneys handling SSRI birth defect lawsuits and Paxil suicide cases at the Los Angeles based Baum, Hedlund, Aristei & Goldman law firm. "The Act is a slippery slope," she warns, "toward the forced drugging of women of childbearing years with drugs of questionable efficacy and serious safety issues effecting mothers and their innocent children – drugs that can cause horrific side effects, including, suicidal behavior, violence and devastating birth defects." "Of course, mothers who truly cannot cope should be helped," Ms Gillespie says, "but do we really need legislation requiring mothers to be screened and drugged?" "Take out politics and Big Pharma and the push for this legislation just doesn’t make sense,” she states. "For politicians, a much safer issue than pushing drugs for pregnant mothers is promoting the expansion of medical treatment for postpartum depression," according to Dr Levine. He says the Mother's Act "omits relevant truths" about Melanie Blocker-Stokes, the woman the bill is named after, and the following information about her suicide should be made known: "Blocker-Stokes... did in fact receive extensive psychiatric treatment. She was hospitalized three times in seven weeks, given four combinations of anti-psychotic, anti-anxiety, and antidepressant medications, and underwent electroconvulsive therapy (electroshock). But despite her psychiatric treatment -- or because of it -- Melanie Blocker-Stokes jumped to her death from the twelfth floor of a Chicago hotel." "There is no evidence that antidepressant use by depressed mothers lowers their likelihood of suicide," Dr Levine says, "and there is a great deal of evidence that antidepressant use can make some people manic, agitated, and violent." Money-making promoters behind the Act Katherine Stone runs an internet website called "Postpartum Progress" and posts a daily blog. She also serves on the board of Postpartum Support International as the public relations outreach chairwoman. Her Bio says she "is a nationally-recognized, award-winning advocate for women with perinatal mood and anxiety disorders." "In 2001," Katherine reports on her website, that "she suffered postpartum obsessive compulsive disorder after the birth of her first child. The feeling of isolation and shame she suffered inspired her to create Postpartum Progress, which has become the most widely-read blog in the United States on postpartum depression, postpartum OCD, antepartum depression, postpartum PTSD and postpartum psychosis." On another page titled, "The Art of Psychiatric Medication," Katherine tells women to hang in there if a medication does not work because for her diagnosis of OCD, she states: "I've taken many medications, including Effexor, Celexa, Seroquel, Risperdal, Wellbutrin, Luvox, Cymbalta, etc. Throughout all of them, I was on the road to recovery. Some just worked better than others at treating my symptoms." She ends the commentary by telling women: "You will find the right medication for you, and you will get better." The prescribing of seven drugs, including two antipsychotics and five antidepressants, to treat OCD is a typical example of the profit-driven drugging that women snagged by the Mother's Act will face, but it's a far cry from the description Katherine wrote about regarding the comparatively minor treatment she received, when she stated in the June 7, 2004 issue of Newsweek, “in my case, that meant taking an antidepressant and going for weekly therapy sessions.” Aside from all the serious health risks now known to be associated with these drugs, most women could not afford the 7-drug "cure" that Katherine ingested. According to DrugStore.com in December 2008, from first to last, at a middle dose for a 30-day supply, the drugs would cost: Effexor $197.86, Celexa $279.92, Seroquel $388.38, Risperdal $652.07, Wellbutrin XI $202.08, Luvox CR $135.99, and Cymbalta $366.62. The cost of "etc" is impossible to calculate without knowing how many more drugs she took. In a March 11, 2009 Postpartum Progress blog, Katherine plugs herself for speaking jobs, along with a study that concluded "the Internet is a viable and feasible tool to screen for PPD." "I'll be adding this study to the speech I give on how women with perinatal mood and anxiety disorders use the Internet," she reports, and then adds: "If you're interested in having me speak at your event, let me know!” The blog carried a live link to a page where “you can scroll down, enter your zip code and generate letters of support in a matter of seconds for the Melanie Blocker Stokes MOTHERS Act that will be sent to your local Congresspeople and Senators.” Katherine further told readers: “I know you’re thinking ‘but I already did that last year.’ Well that was then and this is now. Do it again.” The 2006 Annual Report shows that AstraZeneca gave the group more than $500,000. Abbott Labs, Bristol-Myers Squibb and Wyeth gave between $150,000 and $499,000, and Forest Labs, Glaxo, Janssen, Pfizer, and Shire Pharmaceuticals each gave between $10,000 and $149,000. The Depression and Bipolar Support Alliance in Baltimore also received $5,000 from Eli Lilly in the first quarter of 2008, according to Lilly's grant report. In the section of the 2007 Annual report "at a Glance: How We Met Our Mission," among the things accomplished by the group, it states: "Promoted Melanie Blocker-Stokes Postpartum Depression Research & Care Act at invitation of Rep. Bobby Rush (D-Ill.) "Promoted MOTHER’s Act at invitation of Sen. Dick Durbin (D-Ill.)" Katherine also provides a link to the PerinatalPro website, where women can find treatment for all the "mood" and "anxiety" disorders diagnosed with internet screenings at "Blue Skye Consulting," where Susan is listed as the Managing Director and Owner. She also served as president of Postpartum Support International from 2006 - 2008, as vice-president and Conference Chair in 2005 - 2006, and will chair the group's President's Advisory Council through 2010. This group brags of being the leading proponent of the Mother's Act. On March 2, 2009, Susan's PerinatalPro Blog announced: "The Melanie Blocker Stokes MOTHERS Act moves forward!" and stated: "Thank you to Congressman Bobby L. Rush, U.S. Senator Robert Menendez and Senator Richard Durbin for your unceasing efforts on behalf of America’s mothers!" She should have thanked these members of Congress for boosting her career status and yearly income from her treatment center, speaking fees and book sales. On PerinatalPro, Susan posts a running list of supporters for the Mother's Act. On March 27, 2009, the list included many drug company funded groups. For instance, the American Psychiatric Association is listed as a supporter. In 2006, the pharmaceutical industry provided close to 30% of the Association’s $62.5 million in financing, according to the July 12, 2008 New York Times. In the first quarter of 2007, Eli Lilly gave the Association grants worth more than $412,000, according to Lilly's grant report. The group also received $623,190 from Lilly in the first quarter of 2008. In her PerinatalPro blogs, Susan has nothing but praise for Katherine's website and directs visitors back to Postpartum Progress with a live link. On March 16, 2009, Katherine posted a "Quick Survey on Postpartum Anxiety," and wrote:
Kleiman must be fabulous because she has three books for sale on Postpartum Progress with links to purchase them on Amazon. In fact, there are a total of fourteen books for sale on Katherine's site from which she most likely gets a kick-back with every sale. Kleiman's survey is an excellent example of the methods used to con women into suspecting they are mentally ill via the "expert" blogs. The preface states: "The questions on this survey can be answered by a new mother of an infant or an empty-nester with good recall of the early days with her baby. Please answer as honestly as you can." The question, capital letters and all, reads: "When you were carrying your baby down a flight of stairs, did you EVER, at ANY time, have ANY thought, image or concern that you could accidentally drop your baby?" The survey further tells women:
Women who take the survey are told nothing about what the results mean; but clearly the seed is planted that something is wrong if you "EVER, at ANY time, have ANY thought, image or concern that you could accidentally drop your baby". Katherine's website also provides links to the "Top Women's PPMD Treatment Programs & Specialists." The first link on the list takes women to the "Emory Women’s Mental Health Program" that primarily focuses on "the evaluation and treatment of emotional disorders during pregnancy and the postpartum period," according to Emory University's website. Lilly's 2008 first quarter grant report shows Emory's Department of Psychiatry received $25,000. The "experts" at Emory include some top pharmaceutical industry shills. For example, a link to "Articles" brings up roughly 90 studies and papers that include the co-author Dr Charles Nemeroff. Nemeroff is on an ever-growing list of academic researchers in the field of psychiatry under investigation by the US Senate Finance Committee for not disclosing millions of dollars of income from the makers of psychotropic drugs. Emory's investigation found he was paid more than $960,000 by Paxil maker, GlaxoSmithKline, from 2000 through 2006, but listed less than $35,000 on his Emory disclosure forms. All totaled, Nemeroff had earnings of $2.8 million from speaking and consulting arrangements with drug companies between 2000 and 2007, but only disclosed a fraction of that amount, according to the Senate Finance Committee reports. On July 23, 2008, Medscape Psychiatry & Mental Health posted an article by Nemeroff titled: "Weighing Risk and Benefit for Treatment of Depression in Pregnancy and Post Partum". On March 17, 2009, the Medscape website stated: "This article is temporarily unavailable." Maybe that's because the "top expert," Dr Nemeroff, recently stepped down as chairman of Emory's psychiatry department. Evelyn Pringle is an investigative journalist focused on exposing corruption in government and corporate America. She can be reached at: epringle05@yahoo.cm This article sponsored by the Baum, Hedlund, Aristei & Goldman law firm www.baumhedlundlaw.com.
|
Now Available from CounterPunch Books! Spell Albuquerque: Waiting for
Lightning
|